Article
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.
Molecular cancer research : MCR - 1 Jul 2017
Mustachio Lisa Maria, Lu Yun, Tafe Laura J, Memoli Vincent, Rodriguez-Canales Jaime, Mino Barbara, Villalobos Pamela Andrea, Wistuba Ignacio, Katayama Hiroyuki, Hanash Samir M, Roszik Jason, Kawakami Masanori, Cho Kwang-Jin, Hancock John F, Chinyengetere Fadzai, Hu Shanhu, Liu Xi, Freemantle Sarah J, Dmitrovsky Ethan
Abstract excerpt
KRAS is frequently mutated in lung cancers and is associated with aggressive biology and chemotherapy resistance. Therefore, innovative approaches are needed to treat these lung cancers. Prior work implicated the IFN-stimulated gene 15 (ISG15) deubiquitinase (DUB) USP18 as having antineoplastic activity by regulating lung cancer growth and oncoprotein stability. This study demonstrates that USP18 affects the...
Topics
Join the communities discussing this publication.
